Article
<i>In vitro</i> teratogenicity testing using a 3D, embryo-like gastruloid system
2021-03-30
Abstract excerpt
Pharmaceuticals that are intended for use in patients of childbearing potential need to be tested for teratogenicity before marketing. Several pharmaceutical companies use animal-free in vitro models which allow a more rapid selection of lead compounds and contribute to 3Rs principles (‘replace, reduce and refine’) by streamlining the selection of promising compounds that are submitted to further regulatory studi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b9b49b2f-a381-5898-9e81-f40912ae4805
- DOI
- 10.1101/2021.03.30.437698
